 |
Georgia Chapter Recipient of Outstanding Chapter Award 1965, 1996, 2000, 2004 & 2009
|
|
2011 Recommended Immunization Schedules ACIP Immunization Recommendations Georgia Registry of Immunization Transactions and Services (GRITS) Georgia Vaccines for Children Program (VFC)
|
Immunization Information For additional information, questions, or concerns please contact Mike Chaney, Immunization Coordinator at (404) 881-5094 or mchaney@gaaap.org
The
During January 1--May 20, 2011, a total of 118 measles cases
were reported to CDC from 23 states and
For vaccine safety, parents trust doctors. Parents trust their children's doctor the most when it comes to pediatric vaccine safety followed by public health officials, U.S. researchers found. To read more Click Here.
Resources from CDC and endorsed by the AAP for Vaccine Conversations with Parents may be found by clicking here . You'll find information on talking with parents about vaccines, understanding vaccines and vaccine safety as well as fact sheets that describe symptoms of infections and benefits and risks of vaccines.
Revised Recommendations for Tdap and Meningococcal Vaccine Administration The Advisory Committee on Immunization Practices recently published revisions to the Tdap recommendations for use in children 7, 8 and 9 years old, adolescents and adults. Tdap is not currently licensed for use in children 7 through 9 years of age. Therefore, use in this age group is considered “off label” until the FDA licenses Tdap for use in this age group. The ACIP also removed the restriction on the use of Tdap that stated there should be at least 2 years between the last Td dose and the Tdap booster. Tdap can now be administered regardless of the interval since the last Td dose. Click Here to see the full ACIP recommendation.
The new recommendations for Meningococcal vaccine include adding a booster dose at age 16 to address waning immunity among older teens. The CDC already recommends routine meningitis vaccination beginning at age 11. The committee also recommended that adolescents who get the first dose of the vaccine at age 13 through 15 get a one-time booster dose five years later. Click Here to see the full recommendation. On August 5, 2010, the Advisory Committee on Immunization Practices (ACIP) recommended that the 2010--11 Afluria vaccine not be administered to children aged 6 months through 8 years. Click Here for the full ACIP recommendation. The 2010-11 Influenza Vaccine Information Statements are now available. For the Live, Intranasal VIS Click Here For the Inactivated Flu Vaccine VIS Click Here Influenza Recommendations, 2010-2011. The 2010 influenza recommendations include new and updated information. Highlights of the 2010 recommendations include 1) a recommendation that annual vaccination be administered to all persons aged ≥6 months for the 2010--11 influenza season; 2) a recommendation that children aged 6 months--8 years whose vaccination status is unknown or who have never received seasonal influenza vaccine before (or who received seasonal vaccine for the first time in 2009--10 but received only 1 dose in their first year of vaccination) as well as children who did not receive at least 1 dose of an influenza A (H1N1) 2009 monovalent vaccine regardless of previous influenza vaccine history should receive 2 doses of a 2010--11 seasonal influenza vaccine (minimum interval: 4 weeks) during the 2010--11 season; 3) a recommendation that vaccines containing the 2010--11 trivalent vaccine virus strains A/California/7/2009 (H1N1)-like (the same strain as was used for 2009 H1N1 monovalent vaccines), A/Perth/16/2009 (H3N2)-like, and B/Brisbane/60/2008-like antigens be used; 4) information about Fluzone High-Dose, a newly approved vaccine for persons aged ≥65 years; and 5) information about other standard-dose newly approved influenza vaccines and previously approved vaccines with expanded age indications. Vaccination efforts should begin as soon as the 2010--11 seasonal influenza vaccine is available and continue through the influenza season. The full recommendation can be found at: http://www.cdc.gov/mmwr/preview/mmwrhtml/rr59e0729a1.htm?s_cid=rr59e0729a1_e In response to reported cases of vaccine-acquired rotavirus infection in infants with severe combined immunodeficiency (SCID) following rotavirus vaccine administration, both Merck & Co. and GlaxoSmithKline Biologicals have revised the prescribing information and patient labeling for their respective rotavirus vaccine products.Click Here for full details. An Updated VIS for Rotavirus vaccine now available. Click Here to see the revised VIS. FDA Recommends Clinicians Resume Use of Rotarix and Continue Use of RotaTeq. Click Here to see the revised recommendations for Rotavirus Vaccines. To view the AAP Policy Statement on the use of PVC13 Click Here The VIS for PCV13 is now available. PCV13
Two HPV VISs are now available, one for each vaccine. Gardasil Cervarix
A special federal court has ruled that thimerosal is not to blame for autism. Click here to read an article related to this ruling. To view the background information and full reports of the special masters Click here
The final ACIP recommendations for PCV13 may be found by Clicking here.
An updated list of Georgia Immunization Program Staff including Immunization Consultants (IPCs) and their geographic areas of responsibility is now available. The IPCs are available to assist you and your staff with VFC and GRITS questions. Click Here to view this list. (5.11.2010)
The March 2010 Issue of the AAP News includes an article with answers to some frequently asked questions about PCV13. Click here to view this article on the AAP News website (login/password is required).
2010-2011 Seasonal Influenza Vaccine: Click here to read information on the vaccine selection for the 2010-2011 influenza season.
Novartis receives FDA approval of Menveo®, a vaccine to prevent meningococcal disease: Click here to see a media release regarding the approval.
Vaccine Information Handout for Parents The Chapter has created a one-page handout for parents on vaccines and vaccine safety. Click here to download a copy for use in your practice.
The Chapter’s EPIC Immunization Education Program website contains current vaccine information statements (VISs) immunization schedules and useful immunization resources.
American Academy of Pediatrics Vaccine Safety Resources Click here to view several resources that the AAP has compiled to help answer questions parents may have about vaccine safety. Updates from CDC on Vaccine Shortages are available by clicking here. For detailed updates on newly licensed vaccines and expanded licensures, please see the AAP Red Book® Online website.
In response to the recent media attention given to vaccines, autism, and other controversies concerning vaccines, the Immunization Action Coalition (IAC) has reprinted a special excerpt from Baby 411 entitled Clear Answers and Smart Advice About Your Baby's Shots. Click here to view the article.
The AAP Private Payer Advocacy Advisory Committee recently revised The Business Case for Pricing Vaccines and Immunization Administration to address how the practicing pediatrician should price vaccines to ensure recovery of direct and indirect costs and what payments are appropriate from the insurers. Click here to view the document.
AAP Refusal to Vaccinate Form Health care providers may decide it is in their best interest to formally document a parent's refusal to accept vaccination for a minor child. This form, which should not be considered a legal document without advice from a lawyer, may be used as a template for such documentation. A Microsoft Word version of the form is available by clicking here.
|